First Time Loading...
H

Hua Medicine
HKEX:2552

Watchlist Manager
Hua Medicine
HKEX:2552
Watchlist
Price: 1.59 HKD -1.24% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Hua Medicine

Wall Street analysts forecast Hua Medicine stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hua Medicine is 3.59 HKD .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
3.59 HKD
126% Upside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
3.59 HKD
126% Upside
Highest
Price Target
Not Available
Hua Medicine Competitors:
Price Targets
Z
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
21% Upside
J
4015
Jamjoom Pharmaceuticals Factory Company SJSC
9% Downside
C
1093
CSPC Pharmaceutical Group Ltd
44% Upside
N
600812
North China Pharmaceutical Co Ltd
139% Upside
Z
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
21% Upside
J
4015
Jamjoom Pharmaceuticals Factory Company SJSC
9% Downside
C
1093
CSPC Pharmaceutical Group Ltd
44% Upside
N
600812
North China Pharmaceutical Co Ltd
139% Upside
000100
Yuhan Corp
13% Upside
AJANTPHARM
Ajanta Pharma Ltd
12% Downside
LLY
Eli Lilly and Co
15% Upside
AARTIDRUGS
Aarti Drugs Ltd
14% Upside

Revenue
Forecast

Revenue Estimate
Hua Medicine

The compound annual growth rate of Hua Medicine's revenue for the next 3 years is 260%.

N/A
Past Growth
260%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Hua Medicine

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Hua Medicine

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hua Medicine's stock price target?
Price Target
3.59 HKD

According to Wall Street analysts, the average 1-year price target for Hua Medicine is 3.59 HKD .

What is Hua Medicine's Revenue forecast?
Projected CAGR
260%

The compound annual growth rate of Hua Medicine's revenue for the next 3 years is 260%.

ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.